ArticleAnnals of hematology2025

Ruxolitinib treatment outcomes in acute graft-versus-host disease (aGvHD) in a real-world setting in Finland.

Eeva Martelin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.